GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Operating Income

The Chemours Co (The Chemours Co) Operating Income : $-124 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co Operating Income?

The Chemours Co's Operating Income for the three months ended in Dec. 2023 was $-8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-124 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. The Chemours Co's Operating Income for the three months ended in Dec. 2023 was $-8 Mil. The Chemours Co's Revenue for the three months ended in Dec. 2023 was $1,361 Mil. Therefore, The Chemours Co's Operating Margin % for the quarter that ended in Dec. 2023 was -0.59%.

The Chemours Co's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Chemours Co's annualized ROC % for the quarter that ended in Dec. 2023 was -0.20%. The Chemours Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.89%.


The Chemours Co Operating Income Historical Data

The historical data trend for The Chemours Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Chemours Co Operating Income Chart

The Chemours Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 412.00 406.00 674.00 786.00 -123.00

The Chemours Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.00 214.00 -397.00 67.00 -8.00

The Chemours Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-124 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Chemours Co  (NYSE:CC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Chemours Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-32 * ( 1 - 67.9% )/( (5226 + 4904)/ 2 )
=-10.272/5065
=-0.20 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

The Chemours Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-72/( ( (3377 + max(621, 0)) + (3476 + max(151, 0)) )/ 2 )
=-72/( ( 3998 + 3627 )/ 2 )
=-72/3812.5
=-1.89 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(753 + 1314 + 671) - (1870 + 0 + 247)
=621

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(509 + 1352 + 670) - (2144 + 0 + 236)
=151

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

The Chemours Co's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-8/1361
=-0.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


The Chemours Co Operating Income Related Terms

Thank you for viewing the detailed overview of The Chemours Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


The Chemours Co (The Chemours Co) Business Description

Traded in Other Exchanges
Address
1007 Market Street, Wilmington, DE, USA, 19801
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.
Executives
Ron Christopher Charles officer: Senior Vice President, People C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers director 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane director 300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko officer: President, Thermal & Specializ C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman officer: Senior Vice President and CFO 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough officer: SVP Corp Communications & CBO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott officer: SVP, Chief Enterprise Transfor C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy director C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar officer: Pres Advanced Performance Mat C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza officer: President, Thermal Spec Solns C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel officer: VP, CAO & Controller C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan officer: SVP, CFO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock officer: SVP, Chief Development Officer C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher officer: SVP, People and Health Service ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801